Literature DB >> 33822092

Dual Azithromycin/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold.

Chris Kenyon1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33822092     DOI： 10.1093/infdis/jiab178

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  1 in total

1.  Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand.

Authors:  Naris Kueakulpattana; Dhammika Leshan Wannigama; Sirirat Luk-In; Parichart Hongsing; Cameron Hurst; Paul G Higgins; Vishnu Nayak Badavath; Piroon Jenjaroenpun; Thidathip Wongsurawat; Nipat Teeratakulpisan; Stephen J Kerr; Shuichi Abe; Phatthranit Phattharapornjaroen; Aye Mya Sithu Shein; Thammakorn Saethang; Naphat Chantaravisoot; Mohan Amarasiri; Tanittha Chatsuwan
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.